In what ways has the quality of medical care improved as a result of the development of drug-eluting stents? How can the quality increase be measured?

In what ways has the cost of medical care changed as a result of drug-eluting stents? When do the changes in cost occur? How are the cost changes perceived by consumers, by health-care providers and by insurance providers, such as Medicare?